CELLIPONT BIOSERVICES SELECTS L7 INFORMATICS FOR ITS FLEXIBLE AND UNIFIED PLATFORM, ENABLING END-TO-END MANUFACTURING
This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics' L7|ESP™ unified platform and its integrated Manufacturing Execution System (MES) application to digitalize its cell therapy manufacturing recipes, streamline technology transfers, and digitally enable its customers.
- This collaboration marks a pivotal moment as Cellipont embraces L7 Informatics' L7|ESP™ unified platform and its integrated Manufacturing Execution System (MES) application to digitalize its cell therapy manufacturing recipes, streamline technology transfers, and digitally enable its customers.
- The deployment of L7|ESP by Cellipont signifies a significant step towards optimizing cell therapy development and manufacturing processes.
- By integrating L7 Informatics' advanced platform, Cellipont Bioservices aims to elevate the quality and efficiency of its services, contributing to advancements in cell therapy development and manufacturing methods and technologies.
- Follow L7 Informatics for more information , or contact the team to learn more about L7|ESP capabilities .